Salvage Local Treatments After Focal Therapy for Prostate Cancer

European urology oncology - Tập 2 Số 5 - Trang 526-538 - 2019
Giancarlo Marra1, Massimo Valério2, Mark Emberton3, Axel Heidenreich4, Juanita Crook5, Alberto Bossi6, Louis L. Pisters7
1Department of Urology, San Giovanni Battista Hospital, Città della Salute e della Scienza and University of Turin, Turin, Italy
2Department of Urology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
3Division of Surgery and Interventional Science, University College London, London, UK
4Department of Urology, Uro-Oncology, Robot-Assisted and Reconstructive Urologic Surgery, University Hospital Cologne, Cologne, Germany
5Department of Surgery, Division of Radiation and Developmental Radiotherapeutics, University of British Columbia, BC Cancer Center for the Southern Interior, Kelowna, Canada
6Department of Urology, Gustave Roussy Cancer Institute, Villejuif, France
7Department of Urology, MD Anderson Cancer Center, TX, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Valerio, 2014, The role of focal therapy in the management of localised prostate cancer: a systematic review, Eur Urol, 66, 732, 10.1016/j.eururo.2013.05.048

Guillaumier, 2018, A multicentre study of 5-year outcomes following focal therapy in treating clinically significant nonmetastatic prostate cancer, Eur Urol, 74, 422, 10.1016/j.eururo.2018.06.006

Marra, 2016, Changing the prostate cancer management pathway: why focal therapy is a step forward, Arch Esp Urol, 69, 271

Valerio, 2017, New and established technology in focal ablation of the prostate: a systematic review, Eur Urol, 71, 17, 10.1016/j.eururo.2016.08.044

van der Poel, 2018, Focal therapy in primary localised prostate cancer: the European Association of Urology position in 2018, Eur Urol, 74, 84, 10.1016/j.eururo.2018.01.001

Marra, 2019, Controversies in MR targeted biopsy: alone or combined, cognitive versus software-based fusion, transrectal versus transperineal approach?, World J Urol, 37, 277, 10.1007/s00345-018-02622-5

Marra, 2018, Focal therapy in localised prostate cancer: real-world urological perspective explored in a cross-sectional European survey, Urol Oncol, 36, 529.e11, 10.1016/j.urolonc.2018.08.013

Heidenreich, 2010, Salvage radical prostatectomy, Panminerva Med, 52, 231

Heidenreich, 2010, Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy, Eur Urol, 57, 437, 10.1016/j.eururo.2009.02.041

Chade, 2012, Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature, Eur Urol, 61, 961, 10.1016/j.eururo.2012.01.022

Zargar, 2017, Salvage robotic prostatectomy for radio recurrent prostate cancer: technical challenges and outcome analysis, Minerva Urol Nefrol, 69, 26

Eandi, 2010, Robotic assisted laparoscopic salvage prostatectomy for radiation resistant prostate cancer, J Urol, 183, 133, 10.1016/j.juro.2009.08.134

Yuh, 2014, Complications and outcomes of salvage robot-assisted radical prostatectomy: a single-institution experience, BJU Int, 113, 769, 10.1111/bju.12595

Dindo, 2004, Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey, Ann Surg, 240, 205, 10.1097/01.sla.0000133083.54934.ae

Mitropoulos, 2012, Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU guidelines panel assessment and recommendations, Eur Urol, 61, 341, 10.1016/j.eururo.2011.10.033

Hamid, 2016, Prostate cancer recurrence after focal therapy: treatment options, Arch Esp Urol, 69, 375

Barret, 2014, How to diagnose and treat focal therapy failure and recurrence?, Curr Opin Urol, 24, 241, 10.1097/MOU.0000000000000052

Chang, 2015, Salvage cryosurgery for locally recurrent prostate cancer after primary cryotherapy, Int Urol Nephrol, 47, 301, 10.1007/s11255-014-0887-7

Wenske, 2013, Salvage cryosurgery of the prostate for failure after primary radiotherapy or cryosurgery: long-term clinical, functional, and oncologic outcomes in a large cohort at a tertiary referral centre, Eur Urol, 64, 1, 10.1016/j.eururo.2012.07.008

Berge, 2014, Morbidity associated with primary high intensity focused ultrasound and redo high intensity focused ultrasound for localized prostate cancer, J Urol, 191, 1764, 10.1016/j.juro.2013.12.036

Blana, 2006, Morbidity associated with repeated transrectal high-intensity focused ultrasound treatment of localized prostate cancer, World J Urol, 24, 585, 10.1007/s00345-006-0107-x

Van Son, 2018, Re-salvage MRI-guided focal high-dose-rate brachytherapy for locally recurrent prostate cancer, Cureus, 10, e2429

Murray, 2017, Irreversible electroporation for prostate cancer as salvage treatment following prior radiation and cryotherapy, Rev Urol, 19, 268

Lebdai, 2015, Feasibility, safety, and efficacy of salvage radical prostatectomy after Tookad® soluble focal treatment for localized prostate cancer, World J Urol, 33, 965, 10.1007/s00345-015-1493-8

Linares Espinos, 2016, Minimally invasive salvage prostatectomy after primary radiation or ablation treatment, Urology, 94, 111, 10.1016/j.urology.2016.04.040

Nunes-Silva, 2017, Effect of prior focal therapy on perioperative, oncologic and functional outcomes of salvage robotic assisted radical prostatectomy, J Urol, 198, 1069, 10.1016/j.juro.2017.05.071

Pasticier, 2008, Salvage radiotherapy after high-intensity focused ultrasound for localized prostate cancer: early clinical results, Urology, 72, 1305, 10.1016/j.urology.2008.02.064

Riviere, 2010, Salvage radiotherapy after high-intensity focused ultrasound for recurrent localised prostate cancer, Eur Urol, 58, 567, 10.1016/j.eururo.2010.06.003

Munoz, 2013, Salvage external beam radiotherapy for recurrent prostate adenocarcinoma after high-intensity focused ultrasound as primary treatment, Urol Int, 90, 288, 10.1159/000345631

Ripert, 2012, Salvage radiotherapy after high-intensity focused ultrasound treatment for localized prostate cancer: feasibility, tolerance and efficacy, Can Urol Assoc J, 6, E179, 10.5489/cuaj.10137

Burton, 2000, Salvage radiotherapy for prostate cancer recurrence after cryosurgical ablation, Urology, 56, 833, 10.1016/S0090-4295(00)00778-0

Hepel, 2008, Intensity-modulated radiotherapy of the prostate after cryotherapy: initial experience, Urology, 72, 1310, 10.1016/j.urology.2008.01.079

Hopper, 2018, Salvage image guided radiation therapy to the prostate after cryotherapy failure, Adv Radiat Oncol, 3, 52, 10.1016/j.adro.2017.09.001

Choi, 2013, Salvage intensity-modulated radiation therapy for locally recurrent prostate cancer after cryotherapy, Clin Genitourin Cancer, 11, 85, 10.1016/j.clgc.2012.09.003

McDonough, 2001, Salvage external beam radiotherapy for clinical failure after cryosurgery for prostate cancer, Int J Radiat Oncol Biol Phys, 51, 624, 10.1016/S0360-3016(01)01694-7

Quarrier, 2013, Treatment of prostate cancer local recurrence after whole-gland cryosurgery with frameless robotic stereotactic body radiotherapy: initial experience, Clin Genitourin Cancer, 11, 89, 10.1016/j.clgc.2012.09.004

Holtzman, 2016, Proton therapy as salvage treatment for local relapse of prostate cancer following cryosurgery or high-intensity focused ultrasound, Int J Radiat Oncol Biol Phys, 95, 465, 10.1016/j.ijrobp.2015.12.351

Marra, 2018, Is it worth to perform radical prostatectomy in a salvage setting? Results of a contemporary multicentre series of 395 cases, Eur Urol Suppl, 17, e564, 10.1016/S1569-9056(18)31234-X

Mottet, 2017, EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent, Eur Urol, 71, 618, 10.1016/j.eururo.2016.08.003

Zaorsky, 2014, A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer, Future Oncol, 10, 457, 10.2217/fon.13.196

Zaorsky, 2013, The dilemma of a rising prostate-specific antigen level after local therapy: what are our options?, Semin Oncol, 40, 322, 10.1053/j.seminoncol.2013.04.011

Perera, 2016, Sensitivity, specificity, and predictors of positive 68Ga-prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and meta-analysis, Eur Urol, 70, 926, 10.1016/j.eururo.2016.06.021

de Rooij, 2016, Accuracy of magnetic resonance imaging for local staging of prostate cancer: a diagnostic meta-analysis, Eur Urol, 70, 233, 10.1016/j.eururo.2015.07.029

Chen M, Zhang Q, Zhang C, et al. Combination of 68Ga-PSMA PET/CT and multiparameter MRI improves the detection of clinically significant prostate cancer: a lesion by lesion analysis. J Nucl Med. In press. https://doi.org/10.2967/jnumed.118.221010.

Gupta N, Bivalacqua TJ, Han M, et al. Evaluating the impact of length of time from diagnosis to surgery in patients with unfavorable intermediate to very high-risk clinically localized prostate cancer. BJU Int. In press. https://doi.org/10.1111/bju.14659.

Hanlon, 2002, Posttreatment prostate-specific antigen nadir highly predictive of distant failure and death from prostate cancer, Int J Radiat Oncol Biol Phys, 53, 297, 10.1016/S0360-3016(02)02717-7

Martinez-Pineiro, 2007, Definition and management of prostate-specific antigen recurrence after local therapy, BJU Int, 100, 32, 10.1111/j.1464-410X.2007.06951.x

Donaldson, 2015, Focal therapy: patients, interventions, and outcomes—a report from a consensus meeting, Eur Urol, 67, 771, 10.1016/j.eururo.2014.09.018

Pisters, 2008, Salvage prostate cryoablation: initial results from the cryo on-line data registry, The Journal of urology, 180, 559, 10.1016/j.juro.2008.04.005